Thymus Therapy is the most important building block for immune therapy. This initial therapy involves a series of thymus extract injections, which activate and balance the body’s immune system.

The thymus gland is located just behind the sternum on top of the heart. This gland is the center of our immune system. The function of the thymus is to produce and “educate” T-lymphocytes (T cells). These cells are critical to the adaptive immune system. The thymus changes its size and function during our life cycle. It is largest and most active in newborns, infants and in the years prior to adolescence. By the early teens, the thymus begins to shrink and thymus tissue is replaced by fatty tissue. Nevertheless, a small amount of T -lymphocyte production and education continues throughout adult life.

Modern day Thymus Therapy was developed by the Swedish doctor Elias Sandberg in the 70’s. Up until then, the classic method of L Cell Therapy developed by Professor Niehans was used. Sandberg switched from using live cells and created an extract made from the thymus gland of 6 month old calves. He was able to produce this thymus extract in a physiological concentration (i.e. the concentration of active ingredients is the same as would occur naturally). He called this new substance THX. This method has been used in Germany now for over 20 years

Due to the reduction of size of the thymus gland during our life cycle, the thymus -related immune response becomes less the older we get. When we reach 50 years old, only about 15% still functions. This leads to a significant increase in infections, cancer, and autoimmune diseases, which increase as we get older.

It is critical that enough of the thymus hormones are present in the extract. These are Thymosin Aphla 1, Thymosin Beta 4 and Thymolin. Unfortunately many thymus products currently in market contain only minimal amounts of these hormones.
A typical Thymus Therapy program involves a course of injections using thymus peptides. This therapy is an important, if not the most important, non-specific immunotherapy. This therapy causes an activating and balancing of the cellular immune system. The method traces back to Dr. Elis Sandberg from Sweden, who was having promising results in treating chronic diseases and cancer as far back as 1938. He developed his own high-molecular extract called THX. By the 1980’s Sandberg had successfully treated more than 50, 000 patients. In addition to the positive results of his treatment, many of his patients experienced significant anti-aging effects.